Plesha Scott M. 4
4 · BIODELIVERY SCIENCES INTERNATIONAL INC · Filed Jan 31, 2022
Insider Transaction Report
Form 4
Plesha Scott M.
President
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-01-27−21,050→ 42,101 totalExercise: $0.00Exp: 2024-01-27→ Common Stock (21,050 underlying) - Exercise/Conversion
Common Stock
2022-01-27+21,050→ 320,924 total - Exercise/Conversion
Common Stock
2022-01-31+10,869→ 331,793 total - Exercise/Conversion
Common Stock
2022-01-31+13,334→ 345,127 total - Award
Stock Options (right to buy)
2022-01-27$3.66/sh+369,721$1,353,179→ 369,721 totalExercise: $3.66Exp: 2032-01-26→ Common Stock (369,721 underlying) - Exercise/Conversion
Restricted Stock Units
2022-01-29−10,869→ 10,870 totalExercise: $0.00Exp: 2023-01-29→ Common Stock (10,869 underlying) - Exercise/Conversion
Restricted Stock Units
2022-01-31−13,334→ 0 totalExercise: $0.00Exp: 2022-01-31→ Common Stock (13,334 underlying) - Award
Restricted Stock Units
2022-01-27+66,257→ 66,257 totalExercise: $0.00Exp: 2025-01-27→ Common Stock (66,257 underlying)
Footnotes (7)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
- [F2]The stock options were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
- [F3]The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
- [F4]Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.
- [F5]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 27, 2021, under the Plan. The remaining RSUs will vest in equal portions on: (i) January 27, 2023; and (ii) January 27, 2024.
- [F6]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 29, 2020, under the Plan. The remaining RSUs vest on January 29, 2023.
- [F7]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 31, 2019, under the Issuer's 2011 Equity Incentive Plan.